Author Index

Search or browse for an author across our entire electronic archive

Search results for: G
Results 221 - 230 of 1441 shown below

  • Gardes, M

    A Chompret, L Brugières, M Ronsin, M Gardes, F Dessarps-Freichey, A Abel, D Hua, L Ligot, M-G Dondon, B Bressac-de Paillerets, T Frébourg, J Lemerle, C Bonaïti-Pellié and J Feunteun

    P53 germline mutations in childhood cancers and cancer risk for carrier individuals

    doi:10.1054/bjoc.2000.1167

  • Gardiner, E

    K-F Chin, J Greenman, E Gardiner, H Kumar, K Topping and J Monson

    Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer

    doi:10.1054/bjoc.2000.1508

  • Gardiner, R A

    K A Landers, H Samaratunga, L Teng, M Buck, M J Burger, B Scells, M F Lavin and R A Gardiner

    Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer

    advance online publication, 2008-07-22 00:00:00.000;

    doi:10.1038/sj.bjc.6604486

  • Gardiner-Garden, M

    V A Heinzelmann-Schwarz, M Gardiner-Garden, S M Henshall, J P Scurry, R A Scolyer, A N Smith, A Bali, P Vanden Bergh, S Baron-Hay, C Scott, D Fink, N F Hacker, R L Sutherland and P M O'Brien

    A distinct molecular profile associated with mucinous epithelial ovarian cancer

    advance online publication, 2006-02-28 00:00:00.000;

    doi:10.1038/sj.bjc.6603003

  • Gardner, C

    C J Twelves, C Gardner, A Flavin, J Sludden, I Dennis, J de Bono, P Beale, P Vasey, C Hutchison, M A Macham, A Rodriguez, I Judson and N M Bleehen

    Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II

    doi:10.1038/sj.bjc.6690598

  • S L Cheeseman, M Brannan, A McGown, P Khan, C Gardner, L Gumbrell, D Dickens and M Ranson

    Phase I and pharmacologic study of CT-2584 HMS, a modulator of phosphatidic acid, in adult patients with solid tumours

    doi:10.1054/bjoc.2000.1503

  • Gardner, J

    J Barwell, L Pangon, A Georgiou, Z Docherty, I Kesterton, J Ball, R Camplejohn, J Berg, A Aviv, J Gardner, B S Kato, N Carter, D Paximadas, T D Spector and S Hodgson

    Is telomere length in peripheral blood lymphocytes correlated with cancer susceptibility or radiosensitivity?

    advance online publication, 2007-11-13 00:00:00.000;

    doi:10.1038/sj.bjc.6604085

  • Gardner, P

    M J Baker, E Gazi, M D Brown, J H Shanks, P Gardner and N W Clarke

    FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer

    advance online publication, 2008-11-04 00:00:00.000;

    doi:10.1038/sj.bjc.6604753

  • Gardner, S H

    S H Gardner, G Hawcroft and M A Hull

    Effect of nonsteroidal anti-inflammatory drugs on beta-catenin protein levels and catenin-related transcription in human colorectal cancer cells

    advance online publication, 2004-06-08 00:00:00.000;

    doi:10.1038/sj.bjc.6601901

  • Gardner, T A

    C Jung, R-S Kim, H Zhang, S-J Lee, H Sheng, P J Loehrer, T A Gardner, M-H Jeng and C Kao

    HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation

    advance online publication, 2005-05-31 00:00:00.000;

    doi:10.1038/sj.bjc.6602631

  • Garduño-Espinosa, J

    I Contreras-Hernández, J F Mould-Quevedo, A Silva, G Salinas-Escudero, M A Villasís-Keever, V Granados-García, G Dávila-Loaiza, J A Petersen and J Garduño-Espinosa

    A pharmaco-economic analysis of second-line treatment with imatinib or sunitinib in patients with advanced gastrointestinal stromal tumours

    advance online publication, 2008-05-27 00:00:00.000;

    doi:10.1038/sj.bjc.6604367